Stocks and Investing
Stocks and Investing
Tue, January 7, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, January 6, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Edward Tenthoff Maintained (VRTX) at Buy with Increased Target to $284 on, Jan 6th, 2020
Edward Tenthoff of Piper Sandler, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Increased Target from $247 to $284 on, Jan 6th, 2020.
Edward has made no other calls on VRTX in the last 4 months.
There are 5 other peers that have a rating on VRTX. Out of the 5 peers that are also analyzing VRTX, 0 agree with Edward's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Edward
- Ying Huang of "B of A Securities" Reiterated at Strong Buy with Increased Target to $245 on, Wednesday, November 20th, 2019
- Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $229 on, Tuesday, November 19th, 2019
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $250 on, Thursday, October 31st, 2019
- Paul Matteis of "Stifel" Maintained at Strong Buy with Increased Target to $229 on, Thursday, October 31st, 2019
- Robyn Karnauskas of "Citigroup" Maintained at Strong Buy with Increased Target to $225 on, Tuesday, October 22nd, 2019